Внутрисосудистая визуализация атеросклеротических бляшек у больных с кардиоренальным синдромом: возможности оптической когерентной томографии

В настоящее время трансплантация почек и применение гемодиализа являются основными методами лечения терминальной почечной недостаточности. При этом главной проблемой при лечении указанной категории пациентов остается высокая смертность, в структуре которой первое место занимают сердечнососудистые заболевания. Показано, что у пациентов с терминальной стадией хронической болезни почек, находящихся на гемодиализе, риск смертности от сердечно-сосудистых заболеваний до 20 раз выше, чем в популяции соответствующего пола и возраста. Указанные данные обусловили целесообразность выделения кардиоренальных взаимоотношений в единый кардиоренальный синдром (КРС). В связи с вышеуказанным особую значимость приобретают методы внутрисосудистой визуализации поражений коронарного русла, в частности оптическая когерентная томография (ОКТ). В настоящем обзоре представлен анализ опубликованных к настоящему времени данных об особенностях и возможностях ОКТ у больных с КРС.

кардиоренальный синдром, оптическая когерентная томография, внутрисосудистая визуализация.

1. Hou F, Jiang J, Chen J, Yu X, Zhou Q, Chen P et al. China collaborative study on dialysis: a multi-centers cohort study on cardiovascular diseases in patients on maintenance dialysis. BioMed Central nephrology. 2012 Aug 30; 13: 94. doi: 10.1186/1471-2369-13-94.

2. Ronco C, House AA, Haapio M. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive care medicine. 2008 May; 34 (5): 957–962. doi: 10.1007/s00134-008-1017-8. Epub 2008 Feb 5.

3. Uemura S, Soeda T, Sugawara Y, Ueda T, Watanabe M, Saito Y. Assessment of Coronary Plaque Vulnerability with Optical Coherence Tomography. Acta Cardiologica Sinica. 2014 Jan; 30 (1): 1–9.

4. Созыкин АВ, Никитин АЭ, Шлыков АВ, Новикова НА, Кузьмина ИВ, Эртман ВГ и др. Поражение ствола левой коронарной артерии при стабильной ишемической болезни сердца: возможности оптической когерентной томографии в выборе врачебной тактики и оптимизации интервенционного лечения. Эндоваскулярная хирургия. 2018; 5 (4): 402–409. doi: 10.24183/24094080-2018-5-4-402-409.

5. Kume T, Uemura S. Current clinical applications of coronary optical coherence tomography. Cardiovascular intervention and therapeutics. 2018 Jan; 33 (1): 1–10. doi: 10.1007/s12928-017-0483-8.

6. Suh WM, Seto AH, Margey RJ, Cruz‑Gonzalez I, Jang IK. Intravascular detection of the vulnerable plaque. Circulation. Cardiovascular imaging. 2011 Mar; 4 (2): 169–178. doi: 10.1161/CIRCIMAGING.110.958777.

7. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W et al. Optical coherence tomography. Science. 1991 Nov 22; 254 (5035): 1178–1181.

8. Jang IK, Bouma BE, Kang DH, Park SJ, Park SW, Seung KB et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. Journal of the American College of Cardiology. 2002 Feb 20; 39 (4): 604–609.

9. Prati F, Regar E, Mintz GS, Arbustini E, Di Mario C, Jang IK et al. Expert’s OCT Review Document. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. European heart journal. 2010 Feb; 31 (4): 401–415. doi: 10.1093/eurheartj/ehp433.

10. Prati F, Guagliumi G, Mintz GS, Costa M, Regar E, Akasaka T et al. Expert’s OCT Review Document. Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures. European heart journal. 2012 Oct; 33 (20): 2513–2520. doi: 10.1093/eurheartj/ehs095.

11. Räber L, Mintz GS, Koskinas KC, Johnson TW, Holm NR, Onuma Y et al. ESC Scientific Document Group. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. European heart journal. 2018 Sep 14; 39 (35): 3281–3300. doi: 10.1093/eurheartj/ehy285.

12. Sinclair H, Bourantas C, Bagnall A, Mintz GS, Kunadian V. OCT for the identification of vulnerable plaque in acute coronary syndrome. Journal of the American College of Cardiology cardiovascular imaging. 2015 Feb; 8 (2): 198–209. doi: 10.1016/j.jcmg.2014.12.005.

13. Boi A, Jamthikar AD, Saba L, Gupta D, Sharma A, Loi B et al. A survey on coronary atherosclerotic plaque tissue characterization in intravascular optical coherence tomography. Current atherosclerosis reports. 2018 May 21; 20 (7): 33. doi: 10.1007/s11883-018-0736-8.

14. Yonetsu T, Jang IK. Advances in intravascular imaging: new insights into the vulnerable plaque from imaging studies. Korean circulation journal. 2018 Jan; 48 (1): 1–15. doi: 10.4070/kcj.2017.0182.

15. Zheng G, Chen J, Lin C, Huang X, Lin J. Effect of statin therapy on fibrous cap thickness in coronary plaques using optical coherence tomography: a systematic review and meta-analysis. Journal of interventional cardiology. 2015 Dec; 28 (6): 514–522. doi: 10.1111/joic.12245.

16. Komukai K, Kubo T, Kitabata H, Matsuo Y, Ozaki Y, Takarada S et al. Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASYFIT study. Journal of the American College of Cardiology. 2014 Dec 2; 64 (21): 2207–2217. doi: 10.1016/j.jacc.2014.08.045.

17. Самойленко ВВ, Шевченко ОП, Бурцев ВИ. Применение статинов в периоперационном периоде с позиций доказательной медицины. Рациональная фармакотерапия в кардиологии. 2014; 10 (5): 548–553.

18. Xing L, Higuma T, Wang Z, Aguirre AD, Mizuno K, Takano M et al. Clinical significance of lipid-rich plaque detected by optical coherence tomography: a 4-year follow-up study. Journal of the American College of Cardiology. 2017 May 23; 69 (20): 2502–2513. doi: 10.1016/j.jacc.2017.03.556.

19. Kume T, Okura H, Yamada R, Koyama T, Fukuhara K, Kawamura A et al. Detection of plaque neovascularization by optical coherence tomography: ex vivo feasibility study and in vivo observation in patients with angina pectoris. The Journal of invasive cardiology. 2016 Jan; 28 (1): 17–22.

20. Nakamura S, Inami S, Murai K, Takano M, Takano H, Asai K et al. Relationship between cholesterol crystals and culprit lesion characteristics in patients with stable coronary artery disease: an optical coherence tomography study. Clinical research in cardiology : official journal of the German Cardiac Society. 2014 Dec; 103 (12): 1015–1021. doi: 10.1007/s00392-014-0748-5.21.

21. Dai J, Tian J, Hou J, Xing L, Liu S, Ma Let al. Association between cholesterol crystals and culprit lesion vulnerability in patients with acute coronary syndrome: An optical coherence tomography study. Atherosclerosis. 2016 Apr; 247: 111–117. doi: 10.1016/j.atherosclerosis.2016.02.010.

22. Arbustini E, Dal Bello B, Morbini P, Burke AP, Bocciarelli M, Specchia G et al. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart. 1999 Sep; 82 (3): 269–272.

23. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arteriosclerosis, thrombosis, and vascular biology. 2000 May; 20 (5): 1262–1275. doi: 10.1161/01.ATV.20.5.1262.

24. Dai J, Xing L, Jia H, Zhu Y, Zhang S, Hu S et al. In vivo predictors of plaque erosion in patients with ST-segment elevation myocardial infarction: a clinical, angiographical, and intravascular optical coherence tomography study. European heart journal. 2018 Jun 7; 39 (22): 20772085. doi: 10.1093/eurheartj/ehy101.

25. Tölle M, Reshetnik A, Schuchardt M, Höhne M, van der Giet M. Arteriosclerosis and vascular calcification: causes, clinical assessment and therapy. European journal of clinical investigation. 2015 Sep; 45 (9): 976–985. doi: 10.1111/eci.12493.

26. Ong DS, Lee JS, Soeda T, Higuma T, Minami Y, Wang Z et al. Coronary calcification and plaque vulnerability: an optical coherence tomographic study. Circulation. Cardiovascular imaging. 2016 Jan; 9 (1). pii: e003929. doi: 10.1161/CIRCIMAGING.115.003929.

27. Chin CY, Matsumura M, Maehara A, Zhang W, Lee CT, Yamamoto MH et al. Coronary plaque characteristics in hemodialysis-dependent patients as assessed by optical coherence tomography. The American journal of cardiology. 2017 May 1; 119 (9): 1313–1319. doi: 10.1016/j.amjcard.2017.01.022.

28. Munnur RK, Nerlekar N, Wong DT. Imaging of coronary atherosclerosis in various susceptible groups. Cardiovascular diagnosis and therapy. 2016 Aug; 6 (4): 382–395. doi: 10.21037/cdt.2016.03.02.

29. Kato K, Yonetsu T, Jia H, Abtahian F, Vergallo R, Hu S et al. Nonculprit coronary plaque characteristics of chronic kidney disease. Circulation. Cardiovascular imaging. 2013 May 1; 6 (3): 448–456. doi: 10.1161/CIRCIMAGING.112.000165.

30. Dai J, Xing L, Hou J, Jia H, Hu S, Tian J et al. Chronic kidney disease predicts coronary plaque vulnerability: an optical coherence tomography study. Coronary artery disease. 2017 Mar; 28 (2): 135–144. doi: 10.1097/MCA.0000000000000452.

31. Sugiyama T, Kimura S, Ohtani H, Yamakami Y, Kojima K, Sagawa Y et al. Impact of chronic kidney disease stages on atherosclerotic plaque components on optical coherence tomography in patients with coronary artery disease. Cardiovascular intervention and therapeutics. 2017 Jul; 32 (3): 216–224. doi: 10.1007/s12928-0160408-y.

32. Minami Y, Wang Z, Aguirre AD, Ong DS, Kim CJ, Uemura S et al. Clinical predictors for lack of favorable vascular response to statin therapy in patients with coronary artery disease: a serial optical coherence tomography study. Journal of the American Heart Association. 2017 Nov 1; 6 (11). pii: e006241. doi: 10.1161/JAHA.117.006241.

33. Aoki J, Ikari Y. Cardiovascular disease in patients with end-stage renal disease on hemodialysis. Annals of vascular diseases. 2017 Dec 25; 10 (4): 327–337. doi: 10.3400/avd.ra.17-00051.

34. Karimi Galougahi K, Zalewski A, Leon MB, Karmpaliotis D, Ali ZA. Optical coherence tomography-guided percutaneous coronary intervention in pre-terminal chronic kidney disease with no radio-contrast administration. European heart journal. 2016 Apr 1; 37 (13): 1059. doi: 10.1093/eurheartj/ehv667.

35. Azzalini L, Mitomo S, Hachinohe D, Regazzoli D, Colombo A. Zero-contrast percutaneous coronary intervention guided by dextran-based optical coherence tomography. The Canadian journal of cardiology. 2018 Mar; 34 (3): 342.e1–342.e3. doi: 10.1016/j.cjca.2017.11.008.

36. Koga S, Ikeda S, Nakata T, Kawano H, Abe K, Maemura K. Diverse findings in calcified thrombus between histopathology and in vivo imaging including intravascular ultrasound, optical coherence tomography, and angioscopy. International heart journal. 2015; 56 (6): 661–663. doi: 10.1536/ihj.15-117.

37. Ozaki Y, Kitabata H, Tsujioka H, Hosokawa S, Kashiwagi M, Ishibashi K et al. Comparison of contrast media and low-molecular-weight dextran for frequency-domain optical coherence tomography. Circulation journal: official journal of the Japanese Circulation Society. 2012; 76 (4): 922–927.